LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders
- PMID: 15850991
- DOI: 10.1016/j.jbspin.2004.10.008
LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders
Abstract
The LDL receptor-related protein 5 (LRP5) is a member of the LDL receptor family, which also includes the VLDL receptor and the apolipoprotein E receptor 2. The LRP5 is a co-receptor of Wnt located on the osteoblast membrane between two other receptors, Frizzled and Kremen. Frizzled and LRP5 bind to Wnt, thereby stabilizing beta-catenin and activating bone formation. When the dickkopf protein (Dkk) binds to Kremen and LRP5, this last undergoes internalization and therefore becomes unable to bind Wnt; this leads to degradation of beta-catenin and to inhibition of bone formation. In humans, loss of LRP5 function causes osteoporosis-pseudoglioma syndrome, which is characterized by congenital blindness and extremely severe childhood-onset osteoporosis (lumbar spine Z-score often < -4) with fractures. The G171V mutation prevents Dkk from binding to LRP5, thereby increasing LRP5 function; the result is high bone mass due to uncoupling of bone formation and resorption. The Z-scores in this condition can exceed +6 at the hip and spine. The LRP5 and Wnt/beta-catenin reflect the level of bone formation and play a central role in bone mass accrual and normal distribution. Furthermore, LRP5 may contribute to mediate mechanical loads within bone tissue. Identification of the Wnt/beta-catenin pathway is a breakthrough in the elucidation of pathophysiological mechanisms affecting bone tissue and suggests new treatment targets for patients with osteoporosis or specific malignant conditions such as myeloma and sclerotic bone metastases.
Similar articles
-
Pathogenic mutations and polymorphisms in the lipoprotein receptor-related protein 5 reveal a new biological pathway for the control of bone mass.Curr Opin Lipidol. 2005 Apr;16(2):207-14. doi: 10.1097/01.mol.0000162326.62419.e4. Curr Opin Lipidol. 2005. PMID: 15767861 Review.
-
Novel LRP5 missense mutation in a patient with a high bone mass phenotype results in decreased DKK1-mediated inhibition of Wnt signaling.J Bone Miner Res. 2007 May;22(5):708-16. doi: 10.1359/jbmr.070211. J Bone Miner Res. 2007. PMID: 17295608
-
Clinical and molecular findings in osteoporosis-pseudoglioma syndrome.Am J Hum Genet. 2005 Nov;77(5):741-53. doi: 10.1086/497706. Epub 2005 Sep 27. Am J Hum Genet. 2005. PMID: 16252235 Free PMC article.
-
[Wnt-beta-catenin signaling in bone metabolism].Clin Calcium. 2006 Jan;16(1):54-60. Clin Calcium. 2006. PMID: 16397351 Review. Japanese.
-
High bone density due to a mutation in LDL-receptor-related protein 5.N Engl J Med. 2002 May 16;346(20):1513-21. doi: 10.1056/NEJMoa013444. N Engl J Med. 2002. PMID: 12015390
Cited by
-
SFRP1 promoter methylation and expression in human trabecular meshwork cells.Exp Eye Res. 2012 Apr;97(1):130-6. doi: 10.1016/j.exer.2012.01.003. Epub 2012 Jan 9. Exp Eye Res. 2012. PMID: 22248913 Free PMC article.
-
The role of WNT1 mutant variant (WNT1c.677C>T ) in osteogenesis imperfecta.Ann Hum Genet. 2020 Nov;84(6):447-455. doi: 10.1111/ahg.12399. Epub 2020 Aug 5. Ann Hum Genet. 2020. PMID: 32757296 Free PMC article.
-
LRP5-Mediated Lipid Uptake Modulates Osteogenic Differentiation of Bone Marrow Mesenchymal Stromal Cells.Front Cell Dev Biol. 2021 Nov 2;9:766815. doi: 10.3389/fcell.2021.766815. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34796178 Free PMC article.
-
Signaling Pathways in Bone Development and Their Related Skeletal Dysplasia.Int J Mol Sci. 2021 Apr 21;22(9):4321. doi: 10.3390/ijms22094321. Int J Mol Sci. 2021. PMID: 33919228 Free PMC article. Review.
-
Missense Mutations in LRP5 Associated with High Bone Mass Protect the Mouse Skeleton from Disuse- and Ovariectomy-Induced Osteopenia.PLoS One. 2015 Nov 10;10(11):e0140775. doi: 10.1371/journal.pone.0140775. eCollection 2015. PLoS One. 2015. PMID: 26554834 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous